{"DataElement":{"publicId":"5527443","version":"1","preferredName":"Immunoglobulin Type","preferredDefinition":"Defining name to identify a category of immunoglobulin.","longName":"IMMUNOGLOB_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5527394","version":"1","preferredName":"Immunoglobulin Identification","preferredDefinition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity._The procedure of having an identity established.","longName":"2756911v1.0:2322316v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2756911","version":"1","preferredName":"Immunoglobulin","preferredDefinition":"Glycoproteins present in the blood (ANTIBODIES) and in other tissue. They are classified by structure and activity into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M).","longName":"C572","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin","conceptCode":"C572","definition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF25823-A0A8-67CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"ONEDATA","dateModified":"2008-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322316","version":"1","preferredName":"Identified","preferredDefinition":"Identified; having the identity known or established.","longName":"C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-0624-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F2A244E-EA45-764A-E053-F662850AD1D6","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CRF template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5527442","version":"1","preferredName":"Immunoglobulin Type","preferredDefinition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein erythropoietin (Epo).  Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04)_Type; a subdivision of a particular kind of thing.","longName":"IMMUNOGLOB_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IgA","valueDescription":"IgA","ValueMeaning":{"publicId":"2658038","version":"1","preferredName":"IgA","longName":"2658038","preferredDefinition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgA","conceptCode":"C565","definition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90E4-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F37C10C-BE33-2168-E053-F662850AC503","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"IgM","valueDescription":"IgM","ValueMeaning":{"publicId":"2568587","version":"1","preferredName":"IgM","longName":"2568587","preferredDefinition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgM","conceptCode":"C569","definition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CHILLIJ","dateModified":"2007-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F37C10C-BE3E-2168-E053-F662850AC503","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"IgG","valueDescription":"IgG","ValueMeaning":{"publicId":"2658037","version":"1","preferredName":"IgG","longName":"2658037","preferredDefinition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgG","conceptCode":"C568","definition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90C0-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F37C10C-BE49-2168-E053-F662850AC503","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"IgE","valueDescription":"IgE","ValueMeaning":{"publicId":"2658040","version":"1","preferredName":"IgE","longName":"2658040","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgE","conceptCode":"C567","definition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-914C-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated Definition/Description to match NCIt.  Added text \"In addition to...  ...response in general.\" mcolbert 1/9/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F37C10C-BF8F-2168-E053-F662850AC503","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"},{"value":"IgD","valueDescription":"IgD","ValueMeaning":{"publicId":"2658039","version":"1","preferredName":"IgD","longName":"2658039","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgD","conceptCode":"C566","definition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-9126-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F37C10C-BF9A-2168-E053-F662850AC503","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"ONEDATA","dateModified":"2016-10-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F37C10C-BE1E-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunodeficiency CRF Template.  Value sets are prescribed for that specific set of requirements.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Immunoglobulin","type":"Preferred Question Text","description":"Immunoglobulin","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F37C10C-BE56-2168-E053-F662850AC503","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}